US2006074128A1PendingUtilityA1

Substituted 2-phenyl benzofurans as estrogenic agents

Assignee: WYETH CORPPriority: Dec 18, 2001Filed: Oct 11, 2005Published: Apr 6, 2006
Est. expiryDec 18, 2021(expired)· nominal 20-yr term from priority
A61P 3/10A61P 9/10A61P 5/30A61P 37/06A61P 39/06A61P 7/00A61P 9/00A61P 35/00A61P 3/06A61P 9/12A61P 5/00A61P 9/14A61P 25/00A61P 27/02A61P 29/00A61P 3/00A61P 25/22A61P 25/28C07D 413/04C07D 307/80A61P 1/04A61P 1/00A61P 17/02C07D 405/06A61P 17/06A61P 13/08A61P 13/02A61P 17/00A61P 11/06A61P 1/02A61P 19/02A61P 11/00A61P 15/18A61P 13/10A61P 15/00A61P 13/00
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention provides estrogen receptor modulators of formula 1, having the structure wherein R, R′, A, A′, X, Y, and Y are as defined in the specification, or a pharmaceutically acceptable salt thereof.

Claims

exact text as granted — not AI-modified
1 - 15 . (canceled)  
   
   
       16 . A method of treating or inhibiting arthritis in a mammal in need thereof, which comprises providing to said mammal an effective amount of a compound of formula I, having the structure  
     
       
         
         
             
             
         
       
     
     wherein 
 P and P′ are each, independently, hydrogen, alkyl of 1-6 carbon atoms, or acyl of 2-7 carbon atoms;  
 X is hydrogen or halogen;  
 R is hydrogen, alkyl of 1-6 carbon atoms, halogen, —CN, or —CHO;  
 R′ is alkoxy of 1-6 carbon atoms, or cyanoalkyl having 1-6 carbon atoms in the alkyl moiety;  
 or a pharmaceutically acceptable salt thereof.  
 
   
   
       17 . The method according to  claim 16 , wherein the arthritis is rheumatoid arthritis, osteoarthritis or spondyloarthropathies.  
   
   
       18 . A method of treating or inhibiting joint swelling or erosion; or treating or inhibiting joint damage secondary to arthroscopic or surgical procedures in a mammal in need thereof, which comprises providing to said mammal an effective amount of a compound of formula I, having the structure  
     
       
         
         
             
             
         
       
     
     wherein 
 P and P′ are each, independently, hydrogen, alkyl of 1-6 carbon atoms, or acyl of 2-7 carbon atoms;  
 X is hydrogen or halogen;  
 R is hydrogen, alkyl of 1-6 carbon atoms, halogen, —CN, or —CHO;  
 R′ is alkoxy of 1-6 carbon atoms, or cyanoalkyl having 1-6 carbon atoms in the alkyl moiety;  
 or a pharmaceutically acceptable salt thereof.  
 
   
   
       19 - 22 . (canceled)

Join the waitlist — get patent alerts

Track US2006074128A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.